Invetech - Latest News and Events

David James Speaks on Cell Therapies for Cardiovascular Diseases

Tue, 17 Jan 2012 15:50:00 +1000

Invetech's David James, Director, Life Science and Pharmaceutical, will present at the Conference on Cell Therapy for Cardiovascular Disease, to be held January 25–27 in New York.

Developing the World's First 3D Bioprinter: Invetech addresses the BioMelbourne Network

Fri, 13 Jan 2012 11:11:11 +1000

Invetech's Peter Riddell and Chris Leigh-Lancaster will present the world's first 3D Bioprinter at the BioMelbourne Network Breakfast seminar next month.

FORBES declare the Coca-Cola Freestyle® Coolest Product of the Decade

Thu, 22 Dec 2011 13:25:00 +1000

Coca-Cola Freestyle was recognised by the FORBES as the dispenser that turns the entire drink experience upside-down and inside-out. The publication stated that Freestyle shatters the old model where consumers were boxed into a small range of choices of drinks, and instead blows past the old physical limitations of 8 or 10 choices to a new range of 125 choices all available via a single touch-screen machine.

Invetech and Organovo Win Top Engineering Innovation Honour for the 3D Bioprinter

Wed, 21 Dec 2011 14:15:00 +1000

Invetech, an innovator in new product development for the biomedical, industrial and consumer markets, and San Diego based start-up company, Organovo, have been awarded the prestigious 2011 Australian Engineering Innovation Excellence Award from Engineers Australia for the development of the world's first commercial 3D Bioprinter for human tissue repair and organ replacement.

Invetech to Present at the First Annual SLAS Conference and Exhibition

Mon, 5 Dec 2011 19:15:00 +1000

Invetech's David James, Director, Life Science and Pharmaceutical, and James Atkin, Senior Consultant, will present at the first annual Society for Laboratory Automation and Screening (SLAS) conference and exhibition, to be held in San Diego, California from 4-8 February 2012.

Phacilitate 2012: Invetech to present at 8th Annual Cell & Gene Therapy Forum in Washington

Wed, 30 Nov 2011 15:45:00 +1000

David James, Invetech Director, Life Science and Pharmaceutical, will present at the Phacilitate Cell & Gene Therapy Forum, to be held in January 2012 in Washington, DC. David, in conjunction with key industry leaders, will conduct a Breakfast workshop outlining Cell Therapy commercialisation and ask the critical question, "Cell therapies—are we finally closing the gap?"

Engineers Australia Victorian Division recognizes Invetech and Organovo for 3D bioprinter Excellence in Engineering

Mon, 28 Nov 2011 16:25:00 +1000

Invetech, an innovator in new product development and manufacturing for the biomedical, industrial and consumer markets, has been recognized by the Victoria Division of Engineers Australia with the 2011 Engineering Excellence Award for Research & Development/Innovation. The award recognises and showcases engineering expertise from Invetech and Organovo in the development of the world's first commercial 3D bio-printer.

Invetech honoured at the 2011 Governor of Victoria Export Awards

Thu, 3 Nov 2011 18:20:00 +1000

Invetech, an innovator in new product development and custom automation for the biomedical, industrial and consumer markets, has been awarded a prestigious 2011 Governor of Victoria Export Award for its export success.

David James: Achieving process integrity in cell therapy production

Tue, 20 Sep 2011 15:15:00 +1000

David James, Invetech Director, Life Science and Pharmaceutical, speaks at IBC's inaugural Cell Therapy Bioprocessing conference in Virginia, USA during October.

Diagnostic Marketing Association acknowledges Robert Speziale with the Goldsmith Award for Excellence

Fri, 9 Sep 2011 13:40:00 +1000

Invetech's Robert Speziale has been recognized by the Diagnostic Marketing Association (DxMA) with the Jerry R. Goldsmith Award for Excellence. The Award recognizes contributions made by an individual that impact the growth of the Diagnostic Marketing Association and industry as a whole. Mr. Brian Durkin, President of the DxMA and Vice President at Instrumentation Laboratories presented the Goldsmith Award to Mr. Speziale at the DxMA Annual Dinner in San Diego, CA.

Successfully navigating the product development journey, with Peter Aigner at Biotech in Europe Investor Forum, Zurich

Fri, 9 Sep 2011 13:30:00 +1000

Addressing small start-up companies and investors, Invetech's Peter Aigner shares insights on how working with qualified outsource partners early in the development project reduces development risk, shortens time-to-market and delivers commercial success.

Science, critical thinking & intelligent entertainment: Invetech sponsors denkfest, Zurich

Fri, 29 Jul 2011 13:30:00 +1000

Invetech, in partnership with CONNECT, recently hosted a nearsourcing roundtable "Turning Science Fiction into Science Fact—The Future of Healthcare." The event explored some of the innovative approaches San Diego companies are taking to develop new medical devices, diagnostic tools and gene therapeutics.

Science, critical thinking & intelligent entertainment: Invetech sponsors denkfest, Zurich

Tue, 19 Jul 2011 16:30:00 +1000

Dr. Andreas Koch, Invetech's Business Development Manager, Switzerland, will chair "Cutting Edge Science" at the inaugural denkfest event in Volkshaus Zurich, 8 – 11 September.

Contract manufacturing for competitive advantage: Colin Potter presents at BioForum 2011 in Melbourne

Tue, 19 Jul 2011 16:30:00 +1000

At Bioforum 2011, Colin Potter, Invetech's Director of Contract Manufacturing, will share insights on how to build a competitive advantage through high value product development and manufacturing.

AdvaMed 2011: The MedTech Conference

Fri, 24 June 2011 09:50:05 +1000

Invetech will be attending AdvaMed 2011, the "premier MedTech Conference for CEOs, business executives, policy-makers, financiers, media, and industry stakeholders from around the world".

David James at Bio 2011: Therapies of Tomorrow Require More Than Factories from the Past

Fri, 27 May 2011 16:00:00 +1000

David James, Invetech's Director of Life Science and Pharmaceutical, will present at the 2011 BIOProcess Theatre at the BIO International Convention to be held June 27-30, in Washington DC.

IVD Companies Should Seize Opportunities in the Developing World: Andreas Knaack speaks at AACC International Market Briefing

Fri, 27 May 2011 15:30:00 +1000

Andreas Knaack, Director Biomedical Instruments & Devices, discusses the advantages of making the most of IVD opportunities in emerging markets at the 2011 AACC International Market Briefing, to be held at the Georgia World Congress in July. The briefing is held in conjunction with the AACC Annual Meeting and Clinical Lab Expo.

San Diego Business Journal – Innovation: Helping Companies Move Ideas to Manufacturing

Tue, 10 May 2011 13:30:00 +1000

Invetech was recently recognised by award-winning San Diego Business Journal for the company's ability to help their clients build their commercial success. What makes Invetech innovative is the company's teams of engineers and scientists that combine to create new products for the marketplace, and take a client's project from inception to manufacturing.

Invetech presents on Cell Therapy commercialization strategies at the 17th Annual ISCT Meeting

Wed, 4 May 2011 16:00:00 +1000

David James, Invetech's Director of Life Science and Pharmaceutical, will present at the 17th Annual ISCT meeting, to be held later this month in Rotterdam, The Netherlands. The ISCT is a premier global association started to help drive the translation of scientific research to deliver innovative cellular therapies to patients.

Leica BOND-III Tissue Staining Instrument Wins 2011 Medical Design Excellence Award (MDEA)

Wed, 19 Apr 2011 12:00:00 +1000

The Leica BOND-III instrument, a fully automated sample staining system used in the diagnosis of cancer and infectious diseases, has been awarded the prestigious Medical Design Excellence Award for its innovative design that provides results 50 percent faster than previous generation stainers while also reducing hazardous waste.

The Coca-Cola Freestyle Wins a Gold 2011 Edison Award

Wed, 13 Apr 2011 13:30:00 +1000

Invetech congratulates the Coca-Cola Company on winning the prestigious Gold Award for the Coca-Cola Freestyle at the 2011 Edison Awards' Best New Product Awards, recently announced in New York.

Daniel Schumann named Vice President and Operations Manager of Fast-Growing Invetech San Diego Office

Tue, 5 Apr 2011 13:00:00 +1000

Invetech today announced the appointment of Daniel Schumann, a recognized industry expert in product development and manufacturing, as vice president and operations manager of Invetech's San Diego office to support strategic growth in the U.S. for 2011 and beyond.

Berocca Twist 'N' Go Wins 2011 Beverage Product of the Year

Tue, 24 Mar 2011 15:00:00 +1000

Berocca® Twist 'N' Go, designed and developed by Invetech for Bayer Australia, has been awarded the 2011 Beverage Product of the Year. The award is the only consumer product award that rewards innovation and is voted on by consumers.

Dan Schumann presents to the Diagnostic Marketing Association (DxMA) at Invetech San Diego

Tue, 24 Mar 2011 14:00:00 +1000

Dan Schumann, Invetech Vice President and Operations Manager will share his insights and tips on getting the most out of an outsourcing relationship at next month's DxMA Spring Networking meeting.

The "Future of Healthcare: From Science Fiction to Science Fact" AusMedtech Business Seminar

Tue, 15 Mar 2011 17:00:00 +1000

Next month Invetech will host AusMedtech's first Business Seminar and Networking Event for 2011 at our Melbourne premises. AusMedtech, part of AusBiotech, is Australia's industry group that represents the medical devices and diagnostics industry sector. Their aim is to help facilitate the commercial development of the Australian Medical Device and Diagnostics (Medical Technology) industry.

Invetech Convenes Session at Cell Therapy Europe 2011

Tue, 1 Mar 2011 09:00:00 +1000

Robert Speziale, Invetech, will convene the opening session at CTS Europe 2011, to be held later this month in Maastricht, the Netherlands.

Innovate 2011: The Power of Ideas

Mon, 16 Feb 2011 08:00:00 +1000

Launching to market with the right product at the right time is considered the holy grail of new product development. Join Bill Hill, Invetech's Director Consumer & Industrial and event Chairperson, Warren Hancock, Invetech Director, at Innovate 2011 to be held in Sydney, Australia later this month, to learn more about profitable product development.

Leica BOND III wins an International Design Award

Mon, 1 Feb 2011 15:00:00 +1000

Leica Microsystems has been awarded a prestigious Australian International Design Award for the Leica BOND III instrument, a fully automated staining system that delivers speed, efficiency and quality to histopathology laboratories and hospitals for the detection and diagnosis of cancer and infectious diseases in human tissue samples.

Invetech addresses Zurich industry group on successful Contract Manufacturing in Asia Pacific

Mon, 31 Jan 2011 15:00:00 +1000

Colin Potter, Invetech's Director of Contract Manufacturing, recently addressed a Scientific Forum at Toolpoint for Life Sciences, in Zurich, Swizterland about the critical issues that need to be considered when selecting the right contract manufacturer.

Invetech to present at Phacilitate's 7th annual Cell & Gene Therapy Forum

Mon, 12 Jan 2011 15:00:00 +1000

David James, Invetech's Director Manufacturing Innovation, will present at the Phacilitate Cell & Gene Therapy Forum, to be held later this month in Washington, DC.

Organovo 3D Bio-printer recognized by Time Magazine as one of the 50 Best Inventions for 2010

Mon, 15 Nov 2010 15:00:00 +1000

The 3D Bio-printer has been recognized by Time Magazine as one of the 50 Best Inventions for 2010.

Invetech Delivers First Fully Automated Cell Therapy Units to Argos Therapeutics

Mon, 11 Nov 2010 15:00:00 +1000

Invetech and Argos Therapeutics today announced the delivery of custom designed cell therapy automation units to Argos to facilitate the manufacturing of Argos' personalized RNA-loaded dendritic cell immunotherapies for cancer, HIV and other infectious diseases at commercial scale.

Invetech to present at Smart Surfaces & Cell Therapy Seminar

Mon, 20 Nov 2010 15:00:00 +1000

David James, Invetech's Director Manufacturing Innovation, will present at the Smart Surfaces and Cell Therapy Seminar, to be held next month at the BioSA Incubator Conference Centre.

Invetech Adds Three to Senior Management Team to Support Growth in Medical Devices, Diagnostics and Life Sciences

Mon, 11 Oct 2010 14:00:00 +1000

Invetech has appointed Jeffrey Baltor as vice president of business development, Paul Koenig as program manager for medical devices and Gaizka Navarro as senior software engineer.

Invetech presents at Ausbiotech 2010 on Cell Therapy Commercialisation

Mon, 11 Oct 2010 12:00:00 +1000

To find out more about the challenges being faced in the Cell Therapy market, how companies globally are addressing these and the vital role that Australian companies are playing to help, join Invetech at Ausbiotech 2010.

IVD Technology 15th Anniversary Essays: Instrumentation and Automation

Wed, 15 Sep 2010 16:00:00 +1000

This article, written by Warren Hancock, Invetech Director, examines the various market forces that have shaped the IVD industry and its supporting instrumentation over the last 15 years, and how IVD manufacturers have responded to meet market needs.

PREVI™ Isola Wins Prestigious 2010 Gold Medical Design Excellence Award (MDEA) – developed and manufactured by Invetech

Fri, 16 Jul 2010 09:46:18 +1000

PREVI™ Isola, a breakthrough medical instrument that delivers a faster, more precise and cost-efficient way to process patient specimens, has been awarded the prestigious 2010 Gold Medical Design Excellence Award at the MD&M East Exhibition, New York, NY.

The MDEA award recognizes advances in the design of medical products that improve healthcare delivery and change traditional medical practices.

bioMérieux, a world leader in in vitro diagnostics, partnered with LBT Innovations Ltd, the technology's developer, and Invetech, the instrument’s designer and manufacturer, to create this breakthrough technology. The instrument will greatly improve the efficiency of microbiology labs all over the world by replacing the current time-consuming, costly, manual process of agar plate streaking with a fully automated approach — using a patented applicator to maximize microorganism colony isolation, eliminate cross-contamination risks, and standardize plate inoculation with better traceability.

This award is Invetech's second consecutive MDEA award following TearLab’s win in 2009.

THE ECONOMIST: Printing body parts: Making a bit of me – A machine that prints organs is coming to market.

Fri, 16 Jul 2010 09:46:25 +1000

The Economist explores the world’s first commercial 3D bio-printer for manufacturing human tissue and organs. Initially the printer, developed by Organovo and Invetech, will be used to make only simple tissues, such as skin, muscle and short stretches of blood vessels, however within the next 5 years the opportunity to print blood vessels needed to sustain larger organs like kidneys, livers and hearts will be a possibility.

Victorian Premier congratulates Invetech's manufacturing and world-first product developments

Fri, 16 Jul 2010 09:46:31 +1000

The Victorian Premier John Brumby visited Invetech to inspect its state-of-the-art manufacturing facility and a series of innovative world-firsts including a 3D bio-printer for US life sciences company Organovo.

The Premier congratulated Invetech on its track record in designing, engineering and manufacturing breakthrough products, "Invetech is a leading example of a Victorian manufacturer leading the way not only nationally, but internationally in the innovation and biotech space".

IVD Technology: Finding success through the IVD product definition process

Fri, 16 Jul 2010 09:46:41 +1000

When developing new products for the diagnostic and clinical markets commercial success depends as much on defining the correct product need as it does on finding a good technology solution.

Many companies when bringing a new product to market are driven by perceived needs, past products or a favourite technology that might be newly developed or recently acquired. Rarely is the question "Is this a solution to a problem that my customers care about?" asked, or answered properly.

An Invetech Point of View: Contract Manufacturing – Improving the field reliability of complex instruments

Fri, 16 Jul 2010 09:46:50 +1000

Improving the field reliability of complex diagnostic instruments and medical devices is a critical factor in reducing unscheduled service calls, extending the instruments lifespan and increasing the overall profitability of the instrument.

This paper illustrates the key tasks a contract manufacturing partner can proactively undertake in order to contribute to the increased reliability and long term success of a an instrument.

Invetech delivers Organovo’s first commercial 3D BioPrinter for manufacturing human tissue and organs

Fri, 16 Jul 2010 09:46:57 +1000

Invetech delivered the world's first production model 3D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology. Organovo will supply the units to research institutions investigating human tissue repair and organ replacement.

Dr. Fred Davis, president of Invetech, said, "Building human organs cell-by-cell was considered science fiction not that long ago. Through this clever combination of technology and science we have helped Organovo develop an instrument that will improve people’s lives, making the regenerative medicine that Organovo provides accessible to people around the world."

Invetech's San Diego Facility Supports Partnership with The Coca-Cola Company on "Fountain of the Future"

Fri, 16 Jul 2010 09:47:03 +1000

Invetech is supporting the development of "Coca-Cola Freestyle™", a proprietary new fountain dispenser from The Coca-Cola Company. The stylish new beverage unit, first in a planned family of dispensers, pours more than 100 sparkling and still branded beverages from a single touch-screen machine.

Fred Davis, Invetech’s President commented, "Invetech loves the challenge of innovative projects like the Coca-Cola Freestyle™. Products like this not only have the potential to lead the market, but change the world."

Invetech Raises the Quality Bar at San Diego facility with ISO13485:2003 Compliance for the Design and Development of Medical Devices

Fri, 16 Jul 2010 09:47:15 +1000

Invetech recently received the International Organization for Standardization certification for the San Diego facility, ISO13485:2003, reinforcing its signature development processes and quality management system. The assessment and certification is a cornerstone in ensuring that medical device products designed and developed in Invetech's San Diego facility consistently meet client and customer needs.